{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07037459","recordId":"NCT07037459","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07037459-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07037459.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07037459.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-06-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-06-16","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"e27cfa461c8e42b9f8513cdffdb56c1cc60c1106581f6cec4e650018c5af98b4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-07-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-10","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"d6ec36f53a47a4f28c3f18b3e761d61c1e6f06a29f83d388cd01065cd1dba693","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-07-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-24","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"16fceebdddacbdc0aaffa3ef500df03de2262be60d292cf61a786d87a700d6a8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-07-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-30","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"633c620b4fab4b8faf8220db998fbda0f0a46e1c694fcdeae6342f88356af190","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-08-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-13","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"9c4deed4551fd3dbc998ff070885cdeca28a7e0e51aa9d677264f85b6a069ca3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2025-09-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-03","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"374d288f6a9eb380cdc092011dcaada37cf84f6662b8eb2bbead23755bd46111","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-10","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"63e39feb2d561a615887bcc046b40fc92b124fa1a1f72bd6cdfae2af984a780d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2025-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-17","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"9177abf3ff29a1305987076da42b417e941f943f466e164df31917da5cdff3a1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2025-09-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-24","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"0d517f212bedeedce94d2600da739a62123381bf94a76644a4cd80d02741eb14","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2025-10-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-10-06","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"57a95aac3300f7e1635ebeb22c262ac251ad1b10dfaaa687a33791e690b6abea","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2025-10-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-10-22","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"8a63e7e23574875a5236cb13dfbd489a2348578ae92285dc6cf346fa1c42ab1a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2025-10-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-10-29","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"038946bc8f911e12321c7709b156ce795a9132f3edf0b6240890edafe9b1b52a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2025-11-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-12","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"98dccb0d1150274428737ac1455c9372831768acb3f0625951fad7b30ddb0eb1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2025-12-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-31","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"34d2db7472f5d991bc83fe315b44a8b02a596131ec9ff42ec092e7ac22d70f1e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2026-01-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-07","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"f0d9cec39bd2d9d442afdd1aabed159584b4555c720d9693db7bc7a3e61c9109","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","IPDSharing","Outcome Measures","Study Description","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-01-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-16","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"4e24d43bd8935c5c368c822878068601ccda0db90fda2313330b52f8f1555701","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2026-01-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-21","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"4370768ca9f9e6e76e0768cee831a89a974eef8b64c22a94012bc833fced30a0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2026-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-28","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"5160f5b03f82f3add11f945485d62b75600dc133fc4d7570e2d8ce4ed2f415ab","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2026-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-04","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"8a9b696b38b80e23c5ca20c21fb36982e74c845d192e95dcc012c0666347228b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2026-02-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-11","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"fa9e779a6c0f0df0a2bd044bc62aff483e9bc2452f8b41a229c544dafac273f5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2026-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-18","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"8d145fd6693357e0b02bd2ebf77403a5edee2b3bbb01ee93b5f35cfa5c25faf4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2026-02-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-25","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"1b19e1db01a8b3484553d0b967cc1033778a3a6e374719b556342a067d979dc4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2026-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-27","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"e46c16da25120d299692a8fe38f1cb7f706046875fffba786e7e200fd39edacc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2026-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-01","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"9295660d496d6085d5a1595fabe00a0721ef0f130cd47bb94bf73bde9ceed356","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2026-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-15","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"b02059f54e4bb0d2bb9dca640ee2df4dfe70547be49ca41c91a24850c7b1a64f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2026-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-22","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"6fc90f2925accc6a53e063139601cac05aa27017fa1c768467c0d21e51cc3ecb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2026-05-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-04","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"1cff436d0f3f35334a7f57c516aaef151329816cdac76e17a1324b634156f80c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2026-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-13","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"977133c74f2216e79a4bbb392917af74745ff066c4d37e899819ce491434d1df","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2026-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-20","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"fc4d001ace5296a99c43524bb3366e3cfbfdf518279d77344b91f95df7d47950","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=29&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Status"],"historyVersion":30,"lastUpdateSubmitQcDate":"2026-06-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-30","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"a7ba1af7f6127b864da89815e44a8b41d8d7f107625a3ed9d556be965e5eae97","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=30&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"db745eb8a61c21a33be26871267e84e03d8263bc5e4004024910d0e2620e61ae"}}